Member Info for Shakeyerbooty

Volume certainly picking up.

I believe it was May 2018 BB.

Surely it's got to be close now even allowing for US Dept closures.

READ IQ-AI receives first commercial order for StoneChecker
During a conference call at the end of October, the FDA asked for additional information to be presented to show how the product might work in situations where suboptimal computed tomography (CT) images had been obtained. In response, IQ-AI provided the FDA with additional testing methodology on 27 November for evaluation.

The FDA typically processes 95% of medical device applications within 90 days, so with less than 18 days of 2018 left, it is likely the FDA will not complete its review of the Stonechecker package until the first quarter of next year.

Let's not forget WSG will be paid per container passing through,not just the ones we scan.

Commenting on the Strategic Alliance GAA's Chief Executive Officer, Capt. Dhaffer Al Abbasi, said:



"Joining hands with the world-renowned Westminster Group opens up an array of opportunities, further extending our reach and offering our clients jointly enhanced programs to meet and exceed expectations."

winnie-Milestone payment expected in June as mentioned in recent RNS,so one would expect confirmation of that.Perhaps Spreadex are not quite out yet,but it can't be too long.News will come when we least expect it.People need to realise how far the company has come and the success it has had with NXP001 and the size of the Ebers deal.We are just going through a consolidation period and one or two clowns have decided to show their faces.

Milestone revenues continue to validate Nuformix's business model and its commitment to reinvest early revenues back into R&D, avoiding further fund-raising at this stage whilst maximising the potential value of its cocrystal platform."

Very nice read yuyus.Interesting that it states NXP002 outclassed Esbriet (perfenidone)-the current treatment standard for IPF.

Thanks for posting yuyus.Very,very exciting.

https://www.youtube.com/watch?v=ixGTB-JHZvc

If Spreadex are out and we get broker news plus next milestone payment next week I see no reason why this shouldn't get to 25-30p next week.Considering the £51m cannabinoid deal and success of NXP001 we should be there now.

and we know the firm they appointed to assist them with the regulatory clearance have a 100% record.

Cheers Zengah.Glad to be onboard.

Zengah-you keep saying Q2,so I presume you mean by the end of this month.

Even when Spreadex have been selling,it's been NT to buy on many occasions over the last month or so.So,imagine when they stop shortly coupled with news due on milestone payment,broker etc,how difficult it will be to buy.

I think an RNS is on its way.Somebody somewhere always gets the nod.Let's face it,without Spreadex selling this should have been 20-25p based on cannabinoid deal & NXP001 success.Once we get milestone payment due imminently,broker news and licensing deals,I see no reason why we can't get to 40-50p fairly quickly.Then we've got NXP002 to look forward to.

Going back up as expected.Next news must be fairly imminent re milestone payment.Still very undervalued for a successful pharma co IMO.

Looking at the recent news one can see why,and so it should.The same thing happened at VRS when they had a seller.

I think you mean 10 billion barrels of oil.